Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Background Primary cardiac tumors are rare, accounting for only 0.002-0.03% at autopsy. Cardiac hemangiomas are benign vascular tumors and constitute for 0.28% of all primary cardiac tumors. Cavernous hemangiomas, capillary hemangiomas and arteriovenous hemangiomas are three distinct types. Cardiac hemangiomas are often misdiagnosed as myxomas and must be differentiated from malignant angiosarcomas. Case Summary We present a 44-year-old Mediterranean male patient with a cavernous hemangioma in the inferior vena cava and right atrium, detected on transthoracic echocardiography. The patient experienced palpitations and dyspnea on exertion. CT angiography revealed a 7.5 x 6 x 5cm mass suspected to be perfused by the distal right coronary artery. A watch-and-wait approach was suggested, leading to a Cardiac MRI with contrast six months later. T1-mapping exhibited a prolonged relaxation time and isointensity to the myocardium. T2-mapping revealed a homogenous hyperintense mass with heterogenous Late-Enhancement. Surgical excision was performed using a bicaval cannulation technique on cardiopulmonary bypass. Intraoperatively, no connection to the coronaries was noted. At one year follow-up, the patient reported restored physical resilience, with no evidence of tumor recurrence. Discussion Clinical symptoms of cardiac cavernous hemangiomas are unspecific and become evident once the tumor grows. To investigate the nature and vascular involvement of the tumor, a contrast-enhanced CT angiography or MRI can be performed. Cardiac hemangiomas are often misdiagnosed and must be differentiated from malignant angiosarcomas. Clear guidelines for the treatment of cardiac hemangiomas in adult patients are lacking. Primary cardiac tumors require thorough investigation, and surgical intervention should be tailored to the individual's case.
Background Primary cardiac tumors are rare, accounting for only 0.002-0.03% at autopsy. Cardiac hemangiomas are benign vascular tumors and constitute for 0.28% of all primary cardiac tumors. Cavernous hemangiomas, capillary hemangiomas and arteriovenous hemangiomas are three distinct types. Cardiac hemangiomas are often misdiagnosed as myxomas and must be differentiated from malignant angiosarcomas. Case Summary We present a 44-year-old Mediterranean male patient with a cavernous hemangioma in the inferior vena cava and right atrium, detected on transthoracic echocardiography. The patient experienced palpitations and dyspnea on exertion. CT angiography revealed a 7.5 x 6 x 5cm mass suspected to be perfused by the distal right coronary artery. A watch-and-wait approach was suggested, leading to a Cardiac MRI with contrast six months later. T1-mapping exhibited a prolonged relaxation time and isointensity to the myocardium. T2-mapping revealed a homogenous hyperintense mass with heterogenous Late-Enhancement. Surgical excision was performed using a bicaval cannulation technique on cardiopulmonary bypass. Intraoperatively, no connection to the coronaries was noted. At one year follow-up, the patient reported restored physical resilience, with no evidence of tumor recurrence. Discussion Clinical symptoms of cardiac cavernous hemangiomas are unspecific and become evident once the tumor grows. To investigate the nature and vascular involvement of the tumor, a contrast-enhanced CT angiography or MRI can be performed. Cardiac hemangiomas are often misdiagnosed and must be differentiated from malignant angiosarcomas. Clear guidelines for the treatment of cardiac hemangiomas in adult patients are lacking. Primary cardiac tumors require thorough investigation, and surgical intervention should be tailored to the individual's case.
Background Cavernous hemangioma is a rare benign tumor which can sometimes mimic the clinical presentation and radiological findings of malignant tumors. Here we present a rare presentation of cavernous hemangioma in the mediastinum (CHM), along with a literature review among the main databases. Case presentation We present a 48-year-old male who had suffered from persistent cough as the sole symptom of an anterior CHM. Computed tomography scan demonstrated a 12.5 × 10.8 cm mass in the anterior mediastinum. The mass was surgically resected, and histopathological evaluation established the diagnosis of CHM. The patient was discharged in good condition, in which during his four-month follow-up period, no recurrence of the tumor has been observed. Conclusion Although cavernous hemangioma rarely present in the mediastinum, it should be considered in the differential diagnosis of mediastinal tumors. However, our review of literature demonstrated a female dominance and average age of 40 years, with a 52% mortality rate based on previous reports.
Cardiac hemangioma is a rare, primary, benign cardiac tumor usually diagnosed in young or middle-aged patients. Diagnosis in elderly patients is even rarer. An 80-year-old woman was referred to our hospital with intermittent and worsening left chest discomfort. Transthoracic echocardiography revealed an immobile tumor with broad attachment in the lumen to the anterior wall of the right ventricle. Contrast-enhanced computed tomography revealed an irregular, oval defect in contrast enhancement in the right ventricle. T2-weighted magnetic resonance imaging revealed an oval tumor attached to the anterior wall of the right ventricle. Complete resection of the tumor, including myocardium at the tumor attachment, was performed under cardiopulmonary bypass. The resulting defect in the anterior wall of the right ventricle was repaired with a bovine pericardial patch. Postoperative histopathological examination resulted in the diagnosis of benign cardiac cavernous-capillary type hemangioma. The patient was discharged home on postoperative day 12 without major complications. She has since been followed-up at our outpatient clinic, and has been doing well with no evidence of recurrence as of 3 years postoperatively. We report our experience with this rare case.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.